Liver Disease Treatments: The Global Market

Jun 2015| PHM057C| BCC Publishing

Report Highlights

The global liver diseases therapeutics market totaled nearly $24.5 billion in 2014 and is projected to approach $33.8 billion by 2019, registering a compound annual growth rate (CAGR) of 6.7% through 2019.

Report Includes

  • An overview of the global market for liver disease treatment and related technologies.
  • Analyses of global market trends, with data from 2013 and 2014, and projections of compound annual growth rates (CAGRs) through 2019.
  • Information regarding market sizes, market leaders, market dynamics, and various other market factors, as well as the liver disease treatment market for end users.
  • Analysis of different liver disease drugs in response to an increasing need for new and innovative drug treatments.
  • Comprehensive profiles of major players as well as the acquisitions, mergers, and alliances by these companies and global organizations.

SCOPE OF THE STUDY

The scope of this study encompasses liver disease drug markets by various types. BCC Research analyzes each market by category with its applications in different regions of the world. It also analyzes the regulatory environment, technology and market projections. Application issues include the latest trends and developments in each liver disease drug category.

Analyst Credentials

Yogita Zutshi has worked in clinical operations and market research in pharmaceuticals, including the development of training in pharmacovigilance. She studies products, markets and regulatory environments. She holds a bachelor's degree in education, and master's degrees in clinical research and organic chemistry from Cranfield University.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesPrice Member Price
Full Report: Liver Disease Treatments: The Global Market141 $2,750 Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: EXECUTIVE SUMMARY3$250Free
Chapter- 3: OVERVIEW22$429Free
Chapter- 4: CLASSIFICATION OF THERAPIES BY DISEASE AND PRODUCTS ON THE MARKET12$234Free
Chapter- 5: REGULATORY ASPECTS3$59Free
Chapter- 6: PREVALENCE3$59Free
Chapter- 7: MARKET BY DISEASE TYPE12$234Free
Chapter- 8: PIPELINE6$117Free
Chapter- 9: DRUG-INDUCED LIVER DISEASE7$137Free
Chapter- 10: CURRENT SITUATION AND FUTURE PROSPECTS4$78Free
Chapter- 11: PATENT ANALYSIS49$956Free
Chapter- 12: COMPANY PROFILES17$332Free
Published - Jan-2012| Analyst - Shalini Shahani Dewan| Code - PHM057B

Report Highlights

In 2009, the global market for drugs used to treat liver disease was worth approximately $12.4 billion. Sales in 2010 decreased and the market did not see much progress, causing overall global sales to remain stagnant at $12.4 billion. Estimated sales in 2011 a projected $12 billion (excluding protease inhibitors).  The market is expected to rise at a CAGR of 3.3% and reach nearly $14.2 billion by 2016.

Published - Jun-2009| Analyst - Shalini Shahani Dewan| Code - PHM057A

Report Highlights

  • The global market for liver disease treatments amounted to nearly $8.4 billion in 2007 and is expected to increase to $9.8 billion in 2014, for a compound annual growth rate (CAGR) of 3.0%
  • The treatment for hepatitis is the largest segment of the market, amounting to about $4.6 billion in the last three years, and is expected to reach $4.8 billion in 2014.
  • Sales of targeted therapies were comparatively less in 2008, but this market has the potential to grow faster mainly because of the increased incidence of hepatitis C in developing countries.
Liver Disease Treatments: The Global Market

Single User License: $2750

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
RELATED REPORTS